These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37829941)

  • 21. Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.
    Eldhagen P; Berg S; Lund LH; Sörensson P; Suhr OB; Westermark P
    J Intern Med; 2021 Jun; 289(6):895-905. PubMed ID: 33274477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
    Gertz M; Adams D; Ando Y; Beirão JM; Bokhari S; Coelho T; Comenzo RL; Damy T; Dorbala S; Drachman BM; Fontana M; Gillmore JD; Grogan M; Hawkins PN; Lousada I; Kristen AV; Ruberg FL; Suhr OB; Maurer MS; Nativi-Nicolau J; Quarta CC; Rapezzi C; Witteles R; Merlini G
    BMC Fam Pract; 2020 Sep; 21(1):198. PubMed ID: 32967612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Aortic Stenosis and ATTRwt Amyloidosis - Beware in the Aging: A Case Report and Review of the Literature.
    Adam R; Munteanu A; Mititelu R; Onciul S; Deleanu D; Iliescu VA; Popescu BA; Jurcut R
    Clin Interv Aging; 2020; 15():1863-1872. PubMed ID: 33061335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.
    Penalver J; Ambrosino M; Jeon HD; Agrawal A; Kanjanahattakij N; Pitteloud M; Stempel J; Amanullah A
    Curr Cardiol Rev; 2020; 16(3):221-230. PubMed ID: 31544701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhancing knowledge and awareness of transthyretin cardiac amyloidosis and shared decision-making among cardiology team members in Colorado, USA via an online educational initiative.
    Ismailov RM; Lerut J; Aceña Á; Khasanova ZD
    Hosp Pract (1995); 2022 Feb; 50(1):37-41. PubMed ID: 34879213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
    Nitsche C; Aschauer S; Kammerlander AA; Schneider M; Poschner T; Duca F; Binder C; Koschutnik M; Stiftinger J; Goliasch G; Siller-Matula J; Winter MP; Anvari-Pirsch A; Andreas M; Geppert A; Beitzke D; Loewe C; Hacker M; Agis H; Kain R; Lang I; Bonderman D; Hengstenberg C; Mascherbauer J
    Eur J Heart Fail; 2020 Oct; 22(10):1852-1862. PubMed ID: 32078212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
    Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA
    J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre.
    Dower J; Dima D; Lalla M; Patel AR; Comenzo RL; Varga C
    Br J Cardiol; 2022; 29(2):19. PubMed ID: 36212788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
    Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
    Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
    JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of severe aortic stenosis patients combined with diabetes mellitus after transcatheter aortic valve replacement and short-term outcome.
    Su W; Tai S; Huang Y; Hu X; Zhou S; Fang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):309-318. PubMed ID: 35545323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
    López-Sainz Á; Hernandez-Hernandez A; Gonzalez-Lopez E; Domínguez F; Restrepo-Cordoba MA; Cobo-Marcos M; Gómez-Bueno M; Hernandez-Perez FJ; Oteo JF; Mirelis JG; Cavero MA; Moñivas V; Mingo Santos S; de Haro-Del Moral FJ; Krsnik I; Salas C; Bornstein B; Briceño A; López JA; Vázquez J; Alonso-Pulpón L; Segovia J; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):149-158. PubMed ID: 32317158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications.
    Debonnaire P; Claeys M; De Smet M; Trenson S; Lycke M; Demeester C; Van Droogenbroeck J; De Vriese AS; Verhoeven K; Vantomme N; Van Meirhaeghe J; Willandt B; Lambert M; de Paepe P; Delanote J; De Geeter F; Tavernier R
    Acta Cardiol; 2022 Nov; 77(9):791-804. PubMed ID: 34565298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?
    Rubin J; Alvarez J; Teruya S; Castano A; Lehman RA; Weidenbaum M; Geller JA; Helmke S; Maurer MS
    Amyloid; 2017 Dec; 24(4):226-230. PubMed ID: 28906148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
    Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valve disease in cardiac amyloidosis: an echocardiographic score.
    Aimo A; Fabiani I; Maccarana A; Vergaro G; Chubuchny V; Pasanisi EM; Petersen C; Poggianti E; Giannoni A; Spini V; Taddei C; Castiglione V; Passino C; Fontana M; Emdin M; Venneri L
    Int J Cardiovasc Imaging; 2023 Oct; 39(10):1873-1887. PubMed ID: 37341947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of transcatheter aortic valve replacement on patients with severe aortic stenosis undergoing non-cardiac surgery.
    Omoto T; Aoki A; Maruta K; Masuda T; Horikawa Y
    J Cardiothorac Surg; 2020 Jul; 15(1):198. PubMed ID: 32727528
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.